Member Info for 86KB

Seems like they dont know what to do with the price. All over the place, but expect to be closer to 2p end of week.

Just wondering who the seller is and how much they might have left or if its forward selling. Dont bite just curious if there could be one. As looking at history they usually do one around this time.

When someone is selling 500k, 1 and 2 million tranches you got to take notice. They seem to want above 1.2 to sell. Just w

Noticed someone has been selling since last week everytime bid hits 1.2-1.25

Anyone know who the seller is? Noticed

EU Hydrogen Bank auction starts Dec 3rd ($1.34 billion funding available to EU companies).

In addition to providing significantly enhanced cybersecurity support to the Group's operations, Semnet has been successful in winning additional third-party business, including a US$36 million revenue contract with Ypsilon Technology Pte. Ltd. Semnet is trading ahead of the GST Board's expectations and the business is achieving significant profitable growth.

Taken from 16th Oct Rns "The Company is presently reviewing the current proposal and clarifying its terms where appropriate, and expects to work on detailed contracts with this partner, or one of the other parties, over the coming weeks"

Been about 3 week, not long to wait for update imo.

Oh yes thanks for that AHS, I see the purchase and sale agreement was extended until Nov 30th for EasySend

Expecting interims around 20th Dec looking at history. Possibly other news in between. Trump winning gives another reason for the rise.

There is someone eager to acculmulate 1 million tranches here

Https://x.com/GoLeftMassa/status/1852449691218346294?t=M4xuF8YsNf8y2erDpFQDsg&s=19

I reckon that gap might fill next week betweern 1.6-2.64

Https://x.com/vast_resources/status/1849047938716082432?t=52aLysx0gYZwxdJVSiNHWg&s=19

Thats like over 3600% from current levels. Now brokers targets don't usually hit however there is still a decent upside. People are cautious due to funds and rightly so. But cost cutting and selling assets could sort this issue out. The current mcap is way undervalued considering they have a test to predict patients response to cancer immunotherapy and EpiSwitch Pse for prostate cancer.

Think it should get going soon

Whilst everyone keeps talking about placing just know that they will be looking at licences/assest sale for funds.

It is very oversold still and hasnt started its move back up. 1.67 clears then runs to 2.56. There are gaps at 3.66 and 3.89. If you are looking for higher targets 4p clears then a gap at 5.78p

May have asset sale.

In addition to exploring available funding options, the review will consider a range of potential actions, including but not limited to a licensing or sale of Company assets - such as the EpiSwitch NST and EpiSwitch SCB tests - and a possible hive-off of the Company's US business into a separately funded entity

Its different this time, we should see the gap fill 0.0365. Can't buy at 0.033. Should see 0.034 on ask shortly.

Over 1 billion in volume in half an hour